These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35887664)

  • 1. The Meaning and Reliability of Minimal Important Differences (MIDs) for Clinician-Reported Outcome Measures (ClinROMs) in Dermatology-A Scoping Review.
    Speeckaert R; Belpaire A; Herbelet S; Speeckaert MM; van Geel N
    J Pers Med; 2022 Jul; 12(7):. PubMed ID: 35887664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Credibility and Generalization of the Minimally Important Difference Concept in Dermatology: A Scoping Review.
    Speeckaert R; Belpaire A; Herbelet S; Lambert J; van Geel N
    JAMA Dermatol; 2022 Nov; 158(11):1304-1314. PubMed ID: 36044227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally important difference estimates and methods: a protocol.
    Johnston BC; Ebrahim S; Carrasco-Labra A; Furukawa TA; Patrick DL; Crawford MW; Hemmelgarn BR; Schunemann HJ; Guyatt GH; Nesrallah G
    BMJ Open; 2015 Oct; 5(10):e007953. PubMed ID: 26428330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinician-reported outcome measures for the assessment of vitiligo: A scoping review.
    van Geel N; Duponselle J; Delbaere L; Herbelet S; Eleftheriadou V; Ezzedine K; Forman M; Garg A; Hamzavi IH; Seneschal J; Spuls P; Terwee CB; Wolkerstorfer A; Speeckaert R; Pandya AG
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2231-2242. PubMed ID: 37602494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal important differences for fatigue patient reported outcome measures-a systematic review.
    Nordin Å; Taft C; Lundgren-Nilsson Å; Dencker A
    BMC Med Res Methodol; 2016 May; 16():62. PubMed ID: 27387456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study.
    Devji T; Carrasco-Labra A; Qasim A; Phillips M; Johnston BC; Devasenapathy N; Zeraatkar D; Bhatt M; Jin X; Brignardello-Petersen R; Urquhart O; Foroutan F; Schandelmaier S; Pardo-Hernandez H; Vernooij RW; Huang H; Rizwan Y; Siemieniuk R; Lytvyn L; Patrick DL; Ebrahim S; Furukawa T; Nesrallah G; Schünemann HJ; Bhandari M; Thabane L; Guyatt GH
    BMJ; 2020 Jun; 369():m1714. PubMed ID: 32499297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review.
    Iannone M; Tonini G; Janowska A; Dini V; Romanelli M
    Curr Med Res Opin; 2021 Aug; 37(8):1295-1301. PubMed ID: 34027753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal important differences for improvement in shoulder condition patient-reported outcomes: a systematic review to inform a
    Hao Q; Devji T; Zeraatkar D; Wang Y; Qasim A; Siemieniuk RAC; Vandvik PO; Lähdeoja T; Carrasco-Labra A; Agoritsas T; Guyatt G
    BMJ Open; 2019 Feb; 9(2):e028777. PubMed ID: 30787096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trials.
    Koller M; Musoro JZ; Tomaszewski K; Coens C; King MT; Sprangers MAG; Groenvold M; Cocks K; Velikova G; Flechtner HH; Bottomley A
    Lung Cancer; 2022 May; 167():65-72. PubMed ID: 35413526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of minimal important differences in degenerative knee disease outcomes: a systematic review and case study to inform
    Devji T; Guyatt GH; Lytvyn L; Brignardello-Petersen R; Foroutan F; Sadeghirad B; Buchbinder R; Poolman RW; Harris IA; Carrasco-Labra A; Siemieniuk RAC; Vandvik PO
    BMJ Open; 2017 May; 7(5):e015587. PubMed ID: 28495818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of atopic eczema.
    Werfel T; Claes C; Kulp W; Greiner W; von der Schulenburg JM
    GMS Health Technol Assess; 2006 Oct; 2():Doc19. PubMed ID: 21289970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally Important Differences in Patient or Proxy-Reported Outcome Studies Relevant to Children: A Systematic Review.
    Ebrahim S; Vercammen K; Sivanand A; Guyatt GH; Carrasco-Labra A; Fernandes RM; Crawford MW; Nesrallah G; Johnston BC
    Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28196931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing Minimal Important Differences for the VR-12 and SANE Scores in Patients Following Treatment of Rotator Cuff Tears.
    Zhou L; Natarajan M; Miller BS; Gagnier JJ
    Orthop J Sports Med; 2018 Jul; 6(7):2325967118782159. PubMed ID: 30090834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining minimal important differences for patient-reported outcome measures in shoulder, lateral elbow, patellar and Achilles tendinopathies using distribution-based methods.
    Challoumas D; Zouvani A; Creavin K; Murray E; Crosbie G; Ng N; Millar NL
    BMC Musculoskelet Disord; 2023 Mar; 24(1):158. PubMed ID: 36864412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancer.
    Musoro JZ; Coens C; Greimel E; King MT; Sprangers MAG; Nordin A; van Dorst EBL; Groenvold M; Cocks K; Velikova G; Flechtner HH; Bottomley A;
    Gynecol Oncol; 2020 Nov; 159(2):515-521. PubMed ID: 32972782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mid-term results of minimally invasive deltoid-split versus standard open deltopectoral approach for PHILOS™ (proximal humeral internal locking system) osteosynthesis in proximal humeral fractures.
    Borer J; Schwarz J; Potthast S; Jakob M; Lenzlinger P; Zingg U; Babians A
    Eur J Trauma Emerg Surg; 2020 Aug; 46(4):825-834. PubMed ID: 30643920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic survey identified methodological issues in studies estimating anchor-based minimal important differences in patient-reported outcomes.
    Wang Y; Devji T; Qasim A; Hao Q; Wong V; Bhatt M; Prasad M; Wang Y; Noori A; Xiao Y; Ghadimi M; Lozano LEC; Phillips MR; Carrasco-Labra A; King M; Terluin B; Terwee CB; Walsh M; Furukawa TA; Guyatt GH
    J Clin Epidemiol; 2022 Feb; 142():144-151. PubMed ID: 34752937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the minimal important differences in the RQLQ score with grass and tree allergy immunotherapy versus placebo in adults with moderate-to-severe allergy.
    Blaiss MS; Gronskyte Juhl R; Siew LQC; Hammerby E; Devillier P
    Allergy; 2022 Jun; 77(6):1843-1851. PubMed ID: 34986506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious reporting deficiencies exist in minimal important difference studies: current state and suggestions for improvement.
    Carrasco-Labra A; Devji T; Qasim A; Phillips M; Johnston BC; Devasenapathy N; Zeraatkar D; Bhatt M; Jin X; Brignardello-Petersen R; Urquhart O; Foroutan F; Schandelmaier S; Pardo-Hernandez H; Vernooij RW; Huang H; Rizwan Y; Siemieniuk R; Lytvyn L; Patrick DL; Ebrahim S; Furukawa TA; Nesrallah G; Schunemann HJ; Bhandari M; Thabane L; Guyatt GH
    J Clin Epidemiol; 2022 Oct; 150():25-32. PubMed ID: 35760237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.